CPT drugs-administered-other-than-oral-method-j0013-j8999 Reimbursement & Policy Analysis

HCPCS-J3250-TRIMETHOBENZAMIDE-INJECTION-200MG

HCPCS J3250: Trimethobenzamide Injection, up to 200 mg

HCPCS-J7638-DEXAMETHASONE-INHALATION-SOLUTION-COMPOUNDED-DME

HCPCS Level II J7638: Dexamethasone Inhalation Solution, Compounded

HCPCS-J3472-HYALURONIDASE-OVINE-INJECTION-1000-UNITS

HCPCS Level II J3472: Injection, Hyaluronidase Ovine, Preservative Free

HCPCS-J8612-METHOTREXATE-ORAL-2-5-MG-XATMEP

HCPCS Level II J8612: Methotrexate (xatmep), Oral, 2.5 mg

HCPCS-J7518-MYCOPHENOLIC-ACID-ORAL-180-MG

HCPCS Level II J7518: Mycophenolic Acid, Oral, 180 mg

HCPCS-J1201-CETIRIZINE-INJECTION-0-5-MG

HCPCS J1201: Injection, Cetirizine Hydrochloride 0.5 mg

HCPCS-J1748-INFLIXIMAB-DYYB-ZYMFENTRA-10MG-INJECTION

HCPCS Level II J1748: Injection, infliximab-dyyb (Zymfentra), 10 mg

HCPCS-J2351-OCRELIZUMAB-HYALURONIDASE-INJECTION

HCPCS J2351: Ocrelizumab with Hyaluronidase Injection, 1 mg

HCPCS-J0901-VADADUSTAT-ORAL-1MG-ESRD-DIALYSIS

HCPCS J0901: Vadadustat, oral, 1 mg (ESRD on dialysis)

HCPCS-J0702-BETAMETHASONE-INJECTION-3MG-ACETATE-SODIUM-PHOSPHATE

HCPCS J0702: Betamethasone Injection, Acetate 3 mg / Sodium Phosphate 3 mg